DHODH and familial pancreatic carcinoma: Consistently, we observed an increase of phagocytic macrophages in BAY2402234 treatment group compared with vehicle group (Figure 3J and Supplemental Figure 3P), indicating that pharmacological inhibition of DHODH could inhibit tumor growth and potentiate phagocytosis in pancreatic cancer model.